RBP4 and alkaline phosphatase measurement: It is presumed that fenretinide activates retinoic acid receptors/retinoid-X receptors pathways in tissues that exhibit active metabolic processes, such as liver and adipose tissue [58] These discoveries shed light on treatment modalities for lowering RBP4 in AP.